[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2311536A1 - Guanidines et thiourees, leur procede de preparation et leur application - Google Patents

Guanidines et thiourees, leur procede de preparation et leur application

Info

Publication number
FR2311536A1
FR2311536A1 FR7615253A FR7615253A FR2311536A1 FR 2311536 A1 FR2311536 A1 FR 2311536A1 FR 7615253 A FR7615253 A FR 7615253A FR 7615253 A FR7615253 A FR 7615253A FR 2311536 A1 FR2311536 A1 FR 2311536A1
Authority
FR
France
Prior art keywords
thiourees
guanidines
application
preparation process
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7615253A
Other languages
English (en)
Other versions
FR2311536B1 (fr
Inventor
Graham John Durant
Charon Robin Ganellin
Geoffrey Robert Owen
Rodney Christopher Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB21817/75A external-priority patent/GB1553070A/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2311536A1 publication Critical patent/FR2311536A1/fr
Application granted granted Critical
Publication of FR2311536B1 publication Critical patent/FR2311536B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7615253A 1975-05-21 1976-05-20 Guanidines et thiourees, leur procede de preparation et leur application Granted FR2311536A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21817/75A GB1553070A (en) 1975-05-21 1975-05-21 Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
GB4778275 1975-11-20

Publications (2)

Publication Number Publication Date
FR2311536A1 true FR2311536A1 (fr) 1976-12-17
FR2311536B1 FR2311536B1 (fr) 1979-03-23

Family

ID=26255540

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7615253A Granted FR2311536A1 (fr) 1975-05-21 1976-05-20 Guanidines et thiourees, leur procede de preparation et leur application

Country Status (13)

Country Link
US (6) US4098898A (fr)
JP (1) JPS51141865A (fr)
AT (1) AT356131B (fr)
AU (1) AU503525B2 (fr)
CA (1) CA1076581A (fr)
CH (2) CH626883A5 (fr)
DE (1) DE2621834A1 (fr)
DK (1) DK145541C (fr)
FR (1) FR2311536A1 (fr)
IE (1) IE44062B1 (fr)
IL (1) IL49528A (fr)
NL (1) NL7605405A (fr)
SE (1) SE419544B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010893A1 (fr) * 1978-10-16 1980-05-14 Imperial Chemical Industries Plc Dérivés antisécrétoires hétérocycliques de la guanidine comprenant des chaînes ramifiées, procédés pour leur préparation, produits intermédiaires et compositions pharmaceutiques contenant lesdits dérivés
WO1992015567A1 (fr) * 1991-02-27 1992-09-17 Seed Capital Investment (Sci) B.V. Derives d'imidazoles possedant une activite agoniste ou antagoniste sur le recepteur de l'histamine h3
US5837718A (en) * 1991-02-27 1998-11-17 Seed Capital Investment (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine H3-receptor

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
JPS568357A (en) * 1979-02-16 1981-01-28 Eisai Co Ltd Cyanoguanidine derivative and its production
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4315024A (en) * 1980-08-08 1982-02-09 Cooper Laboratories, Inc. Compositions and method for treating red eye
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4443456A (en) * 1981-05-12 1984-04-17 William H. Rorer, Inc. Pyridyl alkylene amidinoureas
US4810717A (en) * 1981-11-12 1989-03-07 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine aryl ester derivatives
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4795719A (en) * 1984-05-15 1989-01-03 Waferscale Integration, Inc. Self-aligned split gate eprom process
EP0199845B1 (fr) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Dérivés d'imidazolylalkylguanidine, leur procédé de préparation et compositions les contenant
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
NL8601585A (nl) * 1986-06-19 1988-01-18 Vereniging Voor Christelijk Wetenschappelijk Onderwijs N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
US5145860A (en) * 1989-01-05 1992-09-08 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds and pharmaceutical composition comprising the same
US5229386A (en) * 1989-01-05 1993-07-20 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU3467493A (en) * 1992-01-27 1993-09-01 Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
WO2000016766A1 (fr) * 1998-09-22 2000-03-30 Ishihara Sangyo Kaisha Ltd. Composition medicale contenant des derives de nitroetheneamine ou des sels de ces derives comme constituants actifs
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128505A1 (fr) * 1971-03-09 1972-10-20 Smith Kline French Lab

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1305549A (fr) * 1969-10-29 1973-02-07
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4000296A (en) * 1972-09-05 1976-12-28 Smith Kline & French Laboratories Limited Imidazole alkylguanidine compounds
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
US4046907A (en) * 1973-05-17 1977-09-06 Smith Kline & French Laboratories Limited Imidazole alkylaminoethylene compounds
US4124717A (en) * 1973-05-17 1978-11-07 Smith Kline & French Laboratories Limited Thiazolyl alkylaminoethylene compounds
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4152443A (en) * 1973-07-13 1979-05-01 Smith Kline & French Laboratories Limited Imidazolyl thioureas, ureas and guanidines
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4107319A (en) * 1974-03-12 1978-08-15 Smith Kline & French Laboratories Limited Pharmacologically active compounds
US4013769A (en) * 1974-05-09 1977-03-22 Smith Kline & French Laboratories Limited Pyridyl-alkylaminoethylene compounds
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
US4093621A (en) * 1974-09-02 1978-06-06 Smith Kline & French Laboratories Limited Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine
NO781300L (no) * 1977-04-20 1978-10-23 Ici Ltd Fremgangsmaate for fremstilling av fysiologisk aktive guanidinderivater
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128505A1 (fr) * 1971-03-09 1972-10-20 Smith Kline French Lab

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010893A1 (fr) * 1978-10-16 1980-05-14 Imperial Chemical Industries Plc Dérivés antisécrétoires hétérocycliques de la guanidine comprenant des chaînes ramifiées, procédés pour leur préparation, produits intermédiaires et compositions pharmaceutiques contenant lesdits dérivés
WO1992015567A1 (fr) * 1991-02-27 1992-09-17 Seed Capital Investment (Sci) B.V. Derives d'imidazoles possedant une activite agoniste ou antagoniste sur le recepteur de l'histamine h3
US5837718A (en) * 1991-02-27 1998-11-17 Seed Capital Investment (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine H3-receptor

Also Published As

Publication number Publication date
DK145541B (da) 1982-12-06
JPS51141865A (en) 1976-12-07
DK145541C (da) 1983-05-16
IE44062L (en) 1976-11-21
IL49528A0 (en) 1976-07-30
AU1419576A (en) 1977-11-24
NL7605405A (nl) 1976-11-23
US4333946A (en) 1982-06-08
CA1076581A (fr) 1980-04-29
CH624941A5 (fr) 1981-08-31
US4347250A (en) 1982-08-31
US4276301A (en) 1981-06-30
ATA361576A (de) 1979-09-15
US4440775A (en) 1984-04-03
US4247558A (en) 1981-01-27
IL49528A (en) 1980-11-30
FR2311536B1 (fr) 1979-03-23
SE419544B (sv) 1981-08-10
SE7605620L (sv) 1976-11-22
AU503525B2 (en) 1979-09-06
DE2621834A1 (de) 1976-12-02
CH626883A5 (fr) 1981-12-15
AT356131B (de) 1980-04-10
IE44062B1 (en) 1981-08-12
US4098898A (en) 1978-07-04
DK206576A (da) 1976-11-22

Similar Documents

Publication Publication Date Title
FR2311536A1 (fr) Guanidines et thiourees, leur procede de preparation et leur application
FR2319342A1 (fr) Nouvelles cyclobut-1-ene-3,4-diones substituees, leur procede de preparation et leur application
BE845551A (fr) Acides heteroarylbenzoxepine-acetiques, leur procede de preparation et leur application
BE847090A (fr) 15-steroides, et leur procede de preparation
BE846452A (fr) Nouvelles pyrimidones, leur procede de preparation et leur applicationtherapeutique
FR2319343A1 (fr) Nouvelles guanidines, leur procede de preparation et leur application
BE804145A (fr) Guanidines, leur procede de preparation et leur application
BE840798A (fr) Triaryl-1,1,1 alkylamines et leur procede de preparation
FR2301521A1 (fr) Nouvelles n-acyl-n-norsalutaridines et leur procede de preparation
FR2319341A1 (fr) Nouvelles guanidines ou thiourees, leur procede de preparation et leur application
BE845497A (fr) 3-phenylspiro-(isobenzofuranne-1,4'-pipieridine)-sulfenamides, leur procede de preparation et leurs applications
FR2310752A1 (fr) Anthraquinone-bis-amidines, leur procede de preparation et leurs applications
BE855041A (fr) 1-aryloxy-2-hydroxy-3-aminopropanes, leur procede de preparation et leurs applications
BE841814A (fr) Guanidines et thiourees, leur procede de preparation et leurs utilisations
FR2347370A1 (fr) 7-amino-3-tetrazolyl substitue-thiomethyl-cephalosporines et leur procede de preparation
FR2299865A1 (fr) Arylmethyl-1 imidazolidones-2 et leur procede de preparation
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
FR2299300A1 (fr) Trihalogeno-1,1,1-methyl-4-pentene-3-ols-2 et leur procede de preparation
BE849571A (fr) Diurethannes, leur procede de preparation et leur utilisation
FR2333792A1 (fr) 4-hydroxymethyl-2-pyrrolidinones et leur procede de preparation
FR2341572A1 (fr) P-aminophenyl-as-triazine-diones substituees, leur procede de preparation et leurs applications
BE841920A (fr) 1-methyl-2-(pyrilyl-oxymethyl)-nitro-imidazoles, leur procede de preparation et leurs applications
FR2342280A1 (fr) Phenylguanidines substituees, leur procede de preparation et leurs applications
BE842687A (fr) Nouvelles thienyl-prostaglandines, leur procede de preparation et leur application
BE845552A (fr) Phenylsulfenylpiperazines, leur procede de preparation et leurs applications

Legal Events

Date Code Title Description
ST Notification of lapse